Singapore vs Trinidad and Tobago: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Singapore
91.0%
in 2024
Trinidad and Tobago
91.0%
in 2024
Singapore rank
52nd
Trinidad and Tobago rank
52nd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Singapore
- Trinidad and Tobago
How they compare
Singapore currently reports 91.0% against 91.0% in Trinidad and Tobago, a difference of 0.0%.
The two have swapped places 1 time across 13 shared years of data; in 2012 it was Singapore ahead.
Singapore ranks 52nd and Trinidad and Tobago ranks 52nd of 146 countries.
Trinidad and Tobago has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Singapore | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.0% | 85.5% | 12.5% | Trinidad and Tobago |
| 2020s | 89.8% | 93.6% | 3.8% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Singapore or Trinidad and Tobago?
- Singapore, at 91.0% against 91.0% in Trinidad and Tobago as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Singapore and Trinidad and Tobago?
- 0.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Trinidad and Tobago?
- 13 years are reported by both, from 2012 to 2024.
- How do Singapore and Trinidad and Tobago rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Singapore ranks 52nd and Trinidad and Tobago ranks 52nd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.